As of 2025-06-19, the Fair Value of Atossa Therapeutics Inc (ATOS) is -1.02 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.80 USD, the upside of Atossa Therapeutics Inc is -226.96%.
With the market price of 0.80 USD and our fair value calculation, Atossa Therapeutics Inc (ATOS) is not a good investment. Investing in Atossa stocks now will result in a potential loss of 226.96%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -17.83 | -20.61 | -26.96 | -30.09 | -25.50 | -24.20 |
| YoY growth | -3.42% | -15.59% | -30.81% | -11.62% | 15.25% | -9.24% |
| Market Cap (mil) | 103.75 |
| P/E | |
| Forward P/E |
| EPS | -0.20 |
| Avg earnings growth rate | -9.24% |
| TTM earnings | -26.34 |